Status In progress
Process STA
ID number 884

Provisional Schedule

Expected publication 22 November 2017

Project Team

Project lead Thomas Feist

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
28 September 2017 - 12 October 2017 Final appraisal determination
01 March 2017 The committee met to discuss ibrutinib for treating Waldenstrom’s macroglobulinaemia on 15 November 2016. The provisional/draft recommendation that the committee has made requires that the Institute conducts further work before the documentation can be issued. This is to ensure that the recommendation can be implemented once the guidance has been published. We will notify you in due course when we are ready to issue documentation
15 November 2016 Committee meeting: 2
12 October 2016 - 02 November 2016 Appraisal consultation
20 September 2016 Committee meeting: 1
10 April 2016 Invitation to participate
29 March 2016 Draft scope documents
15 March 2016 Referral
25 April 2015 Invitation to participate

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance